Evidence and support

Omega-3 and probiotics for postpartum mood

A large DHA prevention trial did not find a statistically significant benefit on the primary depression outcome. One probiotic strain has an encouraging secondary symptom finding, not proof for all probiotics.

Research preview · selected sources rechecked September 14, 2026 · independent clinical review pending. These editorial assessments are not formal GRADE ratings. No study here establishes an effect of Brighter Postpartum.

The important distinction

Nutrition, prevention and treatment are different questions. A strain-specific finding from a selected sample is not a class effect or a reason to promise mood protection.

mixedprevention · C16

Large DHA prevention trial was not positive

Population and setting: DOMInO trial; 2,399 pregnant participants.
What was found: High EPDS symptoms: 9.67% versus 11.19%; RR 0.85 (95% CI 0.70–1.02), not significant.
Limits and applicability: Nutritional value is not the same as demonstrated depression prevention; formulation and clinical context matter.

Sources: S27

limitedsymptom-support · C17

One probiotic signal is not a class effect

Population and setting: HN001 pregnancy trial; 423 randomized, mood data from 380 participants.
What was found: Mean depression symptom score was 1.2 points lower with HN001.
Limits and applicability: Mood was a secondary outcome, using modified questionnaires. Different strains or a general gut-health bundle are not validated by this result.

Sources: S28

What is a useful food-first action?

Ask someone else to own a meal that fits the mother’s preferences and needs. Do not treat food access as a willpower problem.

Use this as information, not an assessment

Symptoms or concerns deserve appropriate professional care. Severe or worsening symptoms should not wait for an app, a quiz or a two-week threshold.